Short-term tranexamic acid treatment reduces in-hospital mortality in aneurysmal sub-arachnoid hemorrhage: A multicenter comparison study

BACKGROUND: Recurrent bleeding is one of the major causes of morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH). Antifibrinolytic therapy is known to reduce recurrent bleeding, however, its beneficial effect on outcome remains unclear. The effect of treatment with tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Post, R., Germans, M. R., Boogaarts, H. D., Ferreira Dias Xavier, B., Van den Berg, R., Coert, B. A., Vandertop, W. P., Verbaan, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366882/
https://www.ncbi.nlm.nih.gov/pubmed/30730957
http://dx.doi.org/10.1371/journal.pone.0211868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366882/
https://www.ncbi.nlm.nih.gov/pubmed/30730957
http://dx.doi.org/10.1371/journal.pone.0211868

Ejemplares similares